Two Men Sentenced to Prison in $522 Million Medicare Fraud Scheme

A federal judge in an unspecified U.S. district court sentenced two men to prison on May 4, 2026, for their roles in a scheme that defrauded Medicare, Medicaid, and private health insurance companies of more than $522 million through fraudulent claims for medically unnecessary genetic tests, per the U.S. Department of Justice press release.

The fraud affected federal health programs serving elderly and low-income populations, with Medicare covering about 67 million beneficiaries and Medicaid supporting over 80 million enrollees nationwide, based on standard program enrollment data. The scheme involved over $522 million in fraudulent claims, targeting these programs by paying illegal kickbacks and bribes to obtain orders for genetic tests that lacked medical necessity, according to the DOJ release.

Prior to sentencing, the men faced charges for the fraud and kickback violations; now, they will serve prison terms, pay restitution, and face financial penalties as outlined in the court's decision, effective immediately upon sentencing on May 4, 2026, per the DOJ press release.

The sentencing triggers restitution payments to recover portions of the $522 million in fraudulent claims for Medicare and Medicaid, requiring the defendants to compensate the programs directly. It also activates federal oversight mechanisms, where the Department of Health and Human Services may exclude the individuals from participating in federal health programs for a set period.

Prosecutors from the DOJ's Criminal Division can now reference this case in ongoing healthcare fraud investigations, potentially accelerating charges in related probes.

This case marks the latest in the DOJ's Health Care Fraud Strike Force operations, which have charged over 5,400 defendants for more than $27 billion in false billings since 2007, per standard DOJ enforcement records. The genetic testing fraud scheme aligns with a surge in prosecutions targeting laboratory testing scams, following a 2023 DOJ initiative that recovered $2.68 billion from healthcare fraud judgments and settlements.